Therapeutic possibilities in patients with senile dementia.
D000109:Acetylcholine / Q000096:biosynthesis; D000368:Aged; D003704:Dementia / Q000188:drug therapy* / Q000378:metabolism; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D005663:Furans / Q000627:therapeutic use*; D006801:Humans; D007700:Kinetics; D008698:Mesylates / Q000378:metabolism / Q000627:therapeutic use*; D009257:Nafronyl / Q000378:metabolism / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use; D017981:Receptors, Neurotransmitter / Q000187:drug effects
D005663:Furans; D008698:Mesylates; D010276:Parasympatholytics; D010277:Parasympathomimetics; D017981:Receptors, Neurotransmitter; D004088:Dihydroergotoxine; D009257:Nafronyl; D000109:Acetylcholine